Read + Share
Amedeo Smart
Independent Medical Education
Urbanska EM, Sorensen JB, Santoni-Rugiu E. Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population? J Thorac Oncol 2023;18:e28-e29.PMID: 36842817
Email
LinkedIn
Facebook
Twitter
Privacy Policy